LOW vs TRDA · P/E 18, rev $86.29B vs P/E 12, rev $210.8M
Lowe's Companies Inc (LOW) versus Entrada Therapeutics Inc (TRDA) — a side-by-side from cached financials, not a winner call.
Lowe's Companies Inc (LOW) is a home improvement retail company listed on NYSE.
Entrada Therapeutics Inc (TRDA) is a biotechnology company listed on US.
Latest reported LOW revenue for 2026-01-30 was $86.29B. Net income was $6.65B. Revenue was up 3.1% from 2025-01-31 to 2026-01-30. LOW currently screens at market cap $121.89B and trailing P/E 18.4.
Latest reported TRDA revenue for 2024-12-31 was $210.8M. Net income was $65.6M. Revenue was up 63.4% from 2023-12-31 to 2024-12-31. TRDA currently screens at market cap $274.4M and trailing P/E 12.5.
LOW currently screens at market cap $121.89B and trailing P/E 18.4. TRDA currently screens at market cap $274.4M and trailing P/E 12.5.
Not investment advice. Open the LOW and TRDA stock pages for the full models.
Not investment advice.